Fact CheckerSign in

NCT07679724Completed

Evaluation of Oxygen Reserve Index (ORi) in Obese and Non-Obese Patients Over 65 Years Old

Evaluation of Oxygen Reserve Index (ORi) in Obese and Non-Obese Patients Over 65 Years Old Scheduled for Elective Surgery Under General Anesthesia

Source: ClinicalTrials.gov · Last updated 1 Jul 2026

Brief summary (registry, in English)

After obtaining ethical committee approval, this single-center, prospective, observational study included volunteer patients of both sexes, aged 65 years and older, with ASA II-III risk scores, who were scheduled for elective surgery with endotracheal intubation under general anesthesia (GAA). 90 patients were divided into two groups: those with normal BMI (19 \< BMI \< 25 kg/m² (GROUP 1)) and those who were obese (30 \< BMI \< 40 kg/m² (GROUP 2)). In addition to standard ASA monitoring, a finger sensor (Rainbow® SET, Masimo Inc., Irvine, Ca., USA) was implanted for ORi measurement, and baseline values were recorded. Patients were preoxygenated until EtO2 (endtidal oxygen) concentration reached at least 85%. After ORi reached a plateau level, general anesthesia was induced and endotracheal intubation was performed. After confirming the tube's position, the breathing circuit was disconnected from the endotracheal tube, and patients were allowed to be apneic until SpO2 reached 94%. Throughout this process, patients' other vital signs, SpO₂, and ORi were continuously monitored. The time elapsed when ORi triggered an alarm, when SpO2 reached 97%, and when SpO2 reached 94% was recorded. The 'ORi warning time', 'SpO2 warning time', and the 'additional warning time provided by ORi' (the difference between 'ORi warning time' and 'SpO2 warning time') were recorded.

Status (registry)
Completed
Study type
Observational
Enrollment
90 (actual)
First submitted
2 May 2026
Start date
1 Nov 2023
Primary completion date
1 May 2024
Lead sponsor
Ankara City Hospital Bilkent
Diseases
Obesity
NCT number
NCT07679724

What you commit to

  • Study type: Observational
  • Participants enrolled: 90
  • From 1 Nov 2023 to the primary completion date, 1 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with heart and lung disease
  • Patients in situations where the patient is unable to cooperate (e.g., dementia, Alzheimer's)

Age

  • Patients under 65 years of age

Other

  • Patients suspected of having airway difficulties

Who the study is looking for

  • Patients of both sexes aged 65 years and older with ASA II-III risk scores who are scheduled to undergo elective surgical procedures with endotracheal intubation under general anesthesia.

Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Bilkent City Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.